andrewmm2007 | Teon Therapeutics

Chutes & Ladders—Janssen’s US oncology lead jumps to Teon as CEO

by andrewmm2007 | Mar 11, 2022 | Featured News

Fierce Biotech article regarding Teon’s appointment Serge Messerlian as CEO.

Teon Therapeutics Names Serge Messerlian as CEO

by andrewmm2007 | Mar 8, 2022 | Featured Press, Press Releases

Recognized as a visionary industry leader with exceptional experience in buildingorganizations from product development to commercialization, and a strong focus on people, families, and communities affected by cancer Joining team of highly prominent immuno-oncology...

Teon appoints former Janssen exec as CEO

by andrewmm2007 | Mar 8, 2022 | Featured News

Medical Marketing + Media article about Serge Messerlian joining Teon Therapeutics.

PCF 2021: State of Science Report

by andrewmm2007 | Oct 28, 2021 | Publications

Highlights from the 28th Annual PCF Scientific Retreat

AACR Abstract: TT-702, a selective and potent A2B receptor antagonist for the treatment of cancer

by andrewmm2007 | Jul 1, 2021 | Publications

American Association for Cancer Research Abstract 2021

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
laravel_session	30 minutes	laravel uses laravel_session to identify a session instance for a user, this can be changed
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_EH5MV2MF7P	2 years	This cookie is installed by Google Analytics.
_gat_gtag_UA_238867775_1	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.

Chutes & Ladders—Janssen’s US oncology lead jumps to Teon as CEO

Teon Therapeutics Names Serge Messerlian as CEO

Teon appoints former Janssen exec as CEO

PCF 2021: State of Science Report

AACR Abstract: TT-702, a selective and potent A2B receptor antagonist for the treatment of cancer

Stay Connected

Success!